Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypervolemic and Euvolemic Hyponatremia”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableStudy completedNCT02722863
What this trial is testing

Samsca Post Marketing Surveillance Study

Who this might be right for
Hypervolemic and Euvolemic Hyponatremia
Korea Otsuka Pharmaceutical Co., Ltd. 908
Post-approval studies (Phase 4)Study completedNCT04447911
What this trial is testing

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

Who this might be right for
HyponatremiaSIADHLiver Failure+1 more
University Hospital, Basel, Switzerland 113
Large-scale testing (Phase 3)WithdrawnNCT02442674
What this trial is testing

A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia

Who this might be right for
Hyponatremia
Otsuka Pharmaceutical Development & Commercialization, Inc.
Large-scale testing (Phase 3)Ended earlyNCT02012959
What this trial is testing

Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia

Who this might be right for
Hyponatremia
Otsuka Pharmaceutical Development & Commercialization, Inc. 9
Large-scale testing (Phase 3)Ended earlyNCT00843986
What this trial is testing

Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)

Who this might be right for
HyponatremiaAcute Decompensated Heart Failure
Cumberland Pharmaceuticals 9
Large-scale testing (Phase 3)Ended earlyNCT01451411
What this trial is testing

Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia

Who this might be right for
Hyponatremia
Cumberland Pharmaceuticals 4
Large-scale testing (Phase 3)Study completedNCT00492037
What this trial is testing

Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

Who this might be right for
Hyponatremia
Cumberland Pharmaceuticals 83
Large-scale testing (Phase 3)Ended earlyNCT01227512
What this trial is testing

Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia

Who this might be right for
HyponatremiaDilutional HyponatremiaInappropriate ADH Syndrome
Otsuka Pharmaceutical Development & Commercialization, Inc. 124
Large-scale testing (Phase 3)Study completedNCT00478192
What this trial is testing

Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

Who this might be right for
Hyponatremia
Cumberland Pharmaceuticals 50
Not applicableStudy completedNCT01240668
What this trial is testing

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia

Who this might be right for
Euvolemic HyponatremiaHypervolemic Hyponatremia
Otsuka America Pharmaceutical 5,028
Large-scale testing (Phase 3)Study completedNCT00379847
What this trial is testing

An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia

Who this might be right for
Hyponatremia
Cumberland Pharmaceuticals 251
Post-approval studies (Phase 4)Ended earlyNCT01890694
What this trial is testing

Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia

Who this might be right for
Hyponatremia
NYU Langone Health 2
Large-scale testing (Phase 3)WithdrawnNCT00684164
What this trial is testing

Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients

Who this might be right for
Hyponatremia
Columbia University
Not applicableStudy completedNCT01056848
What this trial is testing

International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430

Who this might be right for
Hyponatremia With Normal Extracellular Fluid VolumeHyponatremia With Excess Extracellular Fluid Volume
CardioKine Inc. 135
Post-approval studies (Phase 4)Study completedNCT00435591
What this trial is testing

Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

Who this might be right for
HyponatremiaEuvolemiaHypervolemia
Cumberland Pharmaceuticals 121
Large-scale testing (Phase 3)Study completedNCT00380575
What this trial is testing

Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

Who this might be right for
Hyponatremia
Cumberland Pharmaceuticals 84
Large-scale testing (Phase 3)Ended earlyNCT02020278
What this trial is testing

An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic Hyponatremia

Who this might be right for
Hyponatremia
Otsuka Pharmaceutical Development & Commercialization, Inc. 3